Wilson's disease, also known as liver and brain degeneration, is a hereditary disease caused by excess copper in the body. Symptoms of the disease are often related to the brain and liver, causing a variety of clinical challenges for patients. With the advancement of science and technology, the diagnosis and treatment of Wilson's disease have gradually become more precise, but its complex pathological mechanisms and family genetic background still confuse many patients and their families.
"Copper accumulation caused by Wilson's disease is mainly concentrated in the liver and brain, so liver disease and neuropsychiatric symptoms become the main features of diagnosis."
Wilson's disease has a wide range of symptoms. Because copper cannot be metabolized normally and accumulates in the liver and brain, patients may experience liver problems such as vomiting, fatigue, ascites, leg swelling, yellowing of the skin, and itching. Nervous system effects can lead to tremors, muscle stiffness, speech difficulties, personality changes, anxiety and psychosis. Because these symptoms can intersect with a variety of diseases, diagnosis is particularly difficult in the early stages.
The process of diagnosing Wilson's disease can be a tortuous one, often requiring a comprehensive evaluation that combines blood tests, urine tests, liver biopsies and other examinations. Especially when patients develop neurological symptoms, magnetic resonance imaging (MRI) of the brain can help doctors observe changes in the basal ganglia. Despite these advanced technologies, a completely reliable diagnostic test remains elusive.
“Low serum copper levels appear to be inconsistent with copper excess in Wilson disease, but this is because plasma copper is mainly carried by ceruloplasmin, and ceruloplasmin levels are usually low in Wilson disease patients.”< /p>
Wilson's disease is a genetic disease common in adolescents and adults. The gene mutation occurs in the ATP7B gene, which is responsible for copper metabolism. However, an individual will only develop the disease if both parents carry the mutated gene. According to statistics, about one-third of patients have no clear family history of the disease, which makes genetic screening critical.
Treatment for Wilson's disease usually includes dietary changes and medications. Patients should follow a low-copper diet and avoid foods high in copper, such as nuts, seafood and certain vegetables. At the same time, in terms of drugs, the main ones used include drugs used to reduce copper levels in the body, such as acetate, and drugs that increase copper excretion.
"Maintaining stable copper levels is important. The goal of treatment is not only to reduce copper accumulation, but also to prevent complications."
With the deepening of research in genomics and molecular biology, future treatment options for Wilson's disease will be more targeted. The emergence of early screening and personalized treatment is expected to lead to better prognosis for patients. In addition, family screening and health education cannot be ignored, which will help improve awareness of the disease and enable early detection and early treatment.
In the historical exploration of Wilson's disease, we not only see the progress of medicine, but also the continuous research and reflection of mankind on the disease. As technology develops, can we expect to be able to more effectively control the progression of Wilson's disease in the future and lead to better treatment options?